There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Police in San Diego have released two sets of video footage showing the shooting of an unarmed black man by officers.
Mostly dry across the north of the UK today, with spells of sunshine and isolated heavy showers for some.
Huntingdon's, autism and congenital heart conditions are among those likely to be exempt from reassessment.